Anthrax Lethal Factor Peptide

(IN) Anthrax Lethal Factor peptide

Specyfikacja/Zawartość:

• Tested Applications: Bl
• Applications: Anthrax peptide is used for blocking the activity of Anthrax lethal factor antibody.
• Physical state: Liquid
• Buffer: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide
• Concentration: 200 ug/mL
• NCBI official symbol: pxo1_107
• NCBI gene ID#: 3361711
• NCBI official full name: Lethal factor
• NCBI organism: Bacillus anthracis
• SWISSPROT #: P15917
• Background Reference 1: Bragg TS and Robertson DL. Nucleotide sequence and analysis of the lethal factor gene (lef) from Bacillus anthracis. Gene 1989
• 81:45-54.
• Background Reference 2: Heiser D, Labi V, Erlacher M, et al. The Bcl-2 protein family and its role in the development of neoplastic disease. Exp. Geron. 2004
• 39:1125-35.
• Background Reference 3: Wang K, Yin XM, Chao DT, et al. BID: a novel BH3 domain-only death agonist. Genes Dev. 1996
• 10:2859-69.
• Species: Anthrax lethal factor
• Location: 16 amino acids in the middle of Anthrax lethal factor.

Wysyłka i przechowywanie:

Store Anthrax Lethal Factor peptide at -20°C, stable for one year.

Inne:

This product is for research use only.